Literature DB >> 10983656

Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.

F Baldini1, S Di Giambenedetto, A Cingolani, R Murri, A Ammassari, A De Luca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10983656     DOI： 10.1097/00002030-200007280-00025

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

Review 1.  HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways.

Authors:  Patrick W G Mallon; Andrew Carr; David A Cooper
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 2.  Treatment of dyslipidemia in HIV.

Authors:  Rajagopal V Sekhar
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

Review 3.  Evaluation and management of dyslipidemia in patients with HIV infection.

Authors:  Michael L Green
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

4.  HIV and HAART-Associated Dyslipidemia.

Authors:  Eoin R Feeney; Patrick W G Mallon
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

Review 5.  Evidence-based review of statin use in patients with HIV on antiretroviral therapy.

Authors:  Daniel B Chastain; Kayla R Stover; Daniel M Riche
Journal:  J Clin Transl Endocrinol       Date:  2017-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.